Literature DB >> 21487516

The development of mature B lymphocytes requires the combined function of CD19 and the p110δ subunit of PI3K.

Dorottya Kövesdi1, Sarah E Bell, Martin Turner.   

Abstract

Mice lacking either CD19 or p110δ have reduced numbers of marginal zone and B1 B cells but normal numbers of naïve B2 cells which occupy the follicles of the lymphoid organs. We show here that mice lacking both CD19 and p110δ have normal B cell development in the bone marrow but have a significant reduction in the number of naïve B2 cells in the bone marrow, spleen and lymph nodes. These p110δ/CD19 double mutant B cells show a survival defect and reduced responsiveness to the pro-survival cytokine BAFF despite normal NFκB2/p100 processing and elevated expression of Bcl-2. Although the combined loss of p110δ and CD19 did not increase switching to Ig-lambda in immature B cells, mature B lymphocytes from the lymph nodes of p110δ/CD19 double mutant mice express highly elevated levels of mRNA encoding RAG-1 and RAG-2, which confirms the existing synergy between CD19 and p110δ-mediated signaling.

Entities:  

Year:  2010        PMID: 21487516      PMCID: PMC3065673          DOI: 10.4161/self.1.2.11796

Source DB:  PubMed          Journal:  Self Nonself        ISSN: 1938-2030


  57 in total

1.  FcgammaRIIb-mediated negative regulation of BCR signalling is associated with the recruitment of the MAPkinase-phosphatase, Pac-1, and the 3'-inositol phosphatase, PTEN.

Authors:  Kirsty S Brown; Derek Blair; Steven D Reid; Emma K Nicholson; Margaret M Harnett
Journal:  Cell Signal       Date:  2004-01       Impact factor: 4.315

2.  CD19 function in early and late B cell development: I. Maintenance of follicular and marginal zone B cells requires CD19-dependent survival signals.

Authors:  Dennis C Otero; Amy N Anzelon; Robert C Rickert
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

3.  Regulation of B-cell development by BCAP and CD19 through their binding to phosphoinositide 3-kinase.

Authors:  Yuichi Aiba; Megumi Kameyama; Tetsuo Yamazaki; Thomas F Tedder; Tomohiro Kurosaki
Journal:  Blood       Date:  2007-11-19       Impact factor: 22.113

4.  B cell receptor-mediated sustained c-Rel activation facilitates late transitional B cell survival through control of B cell activating factor receptor and NF-kappaB2.

Authors:  Iris Castro; Jacqueline A Wright; Bazarragchaa Damdinsuren; Kristen L Hoek; Gianluca Carlesso; Nicholas P Shinners; Rachel M Gerstein; Robert T Woodland; Ranjan Sen; Wasif N Khan
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

5.  Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice.

Authors:  R C Rickert; K Rajewsky; J Roes
Journal:  Nature       Date:  1995-07-27       Impact factor: 49.962

6.  IL-2 regulates perforin and granzyme gene expression in CD8+ T cells independently of its effects on survival and proliferation.

Authors:  Michelle L Janas; Penny Groves; Norbert Kienzle; Anne Kelso
Journal:  J Immunol       Date:  2005-12-15       Impact factor: 5.422

7.  The tyrosine kinase Lyn is required for B cell development beyond the T1 stage in the spleen: rescue by over-expression of Bcl-2.

Authors:  Josephine Meade; Claire Fernandez; Martin Turner
Journal:  Eur J Immunol       Date:  2002-04       Impact factor: 5.532

8.  Altered splenic B cell subset development in mice lacking phosphoinositide 3-kinase p85alpha.

Authors:  Amber C Donahue; Kristen L Hess; Kwan L Ng; David A Fruman
Journal:  Int Immunol       Date:  2004-11-01       Impact factor: 4.823

9.  The tyrosine kinase Syk is required for light chain isotype exclusion but dispensable for the negative selection of B cells.

Authors:  Josephine Meade; Victor L J Tybulewicz; Martin Turner
Journal:  Eur J Immunol       Date:  2004-04       Impact factor: 5.532

10.  The 3BP2 adapter protein is required for optimal B-cell activation and thymus-independent type 2 humoral response.

Authors:  Grace Chen; Ioannis D Dimitriou; Jose La Rose; Subburaj Ilangumaran; Wen-Chen Yeh; Gina Doody; Martin Turner; Jennifer Gommerman; Robert Rottapel
Journal:  Mol Cell Biol       Date:  2007-02-05       Impact factor: 4.272

View more
  4 in total

1.  Sprague Dawley Rag2-Null Rats Created from Engineered Spermatogonial Stem Cells Are Immunodeficient and Permissive to Human Xenografts.

Authors:  Fallon K Noto; Valeriya Adjan-Steffey; Goutham Narla; Tseten Y Jamling; Min Tong; Kameswaran Ravichandran; Wei Zhang; Angela Arey; Christopher B McClain; Eric Ostertag; Sahar Mazhar; Jaya Sangodkar; Analisa DiFeo; Jack Crawford
Journal:  Mol Cancer Ther       Date:  2018-09-11       Impact factor: 6.261

2.  Idelalisib Impacts Cell Growth through Inhibiting Translation-Regulatory Mechanisms in Mantle Cell Lymphoma.

Authors:  Qingshan Yang; Lisa S Chen; Min Jin Ha; Kim-Anh Do; Sattva S Neelapu; Varsha Gandhi
Journal:  Clin Cancer Res       Date:  2016-06-24       Impact factor: 12.531

3.  Active PI3K abrogates central tolerance in high-avidity autoreactive B cells.

Authors:  Sarah A Greaves; Jacob N Peterson; Pamela Strauch; Raul M Torres; Roberta Pelanda
Journal:  J Exp Med       Date:  2019-04-04       Impact factor: 14.307

4.  The phosphoinositide 3-kinase signaling pathway in normal and malignant B cells: activation mechanisms, regulation and impact on cellular functions.

Authors:  Samantha D Pauls; Sandrine T Lafarge; Ivan Landego; Tingting Zhang; Aaron J Marshall
Journal:  Front Immunol       Date:  2012-08-09       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.